NasdaqCM - Nasdaq Real Time Price USD
Adverum Biotechnologies, Inc. (ADVM)
2.4700
-0.0400
(-1.59%)
At close: June 4 at 4:00:01 PM EDT
2.5900
+0.12
+(4.86%)
After hours: June 4 at 5:10:25 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 4 |
| Avg. Estimate | -2.29 | -0.9 | -5.62 | -2.85 |
| Low Estimate | -2.4 | -1.19 | -6.63 | -4.34 |
| High Estimate | -2.25 | -0.56 | -3.54 | -2.05 |
| Year Ago EPS | -0.89 | -1.3 | -6.62 | -5.62 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 5 | 5 | 4 | 4 |
| Avg. Estimate | -- | -- | 237.5k | 225.75k |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | 950k | 903k |
| Year Ago Sales | -- | 1M | 1M | 237.5k |
| Sales Growth (year/est) | 0.00% | -100.00% | -76.25% | -4.95% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -1.47 | -1.3 | -1.38 | -1.97 |
| EPS Actual | -0.89 | -1.3 | -1.96 | -2.25 |
| Difference | 0.58 | 0 | -0.58 | -0.28 |
| Surprise % | 39.52% | 0.13% | -41.52% | -13.98% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -2.29 | -0.9 | -5.62 | -2.85 |
| 7 Days Ago | -2.29 | -0.9 | -5.65 | -2.42 |
| 30 Days Ago | -1.88 | -0.95 | -4.98 | -2.63 |
| 60 Days Ago | -1.36 | -1.25 | -4.34 | -3.8 |
| 90 Days Ago | -1.36 | -1.25 | -4.34 | -3.8 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 2 | 1 |
| Down Last 7 Days | 2 | 2 | 2 | 2 |
| Down Last 30 Days | 1 | 1 | 2 | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| ADVM | -157.58% | 30.77% | 15.11% | 49.38% |
| S&P 500 | 13.08% | 2.49% | 7.56% | 13.97% |
Upgrades & Downgrades
| Maintains | RBC Capital: Sector Perform to Sector Perform | 5/15/2025 |
| Maintains | Chardan Capital: Buy to Buy | 5/15/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 5/15/2025 |
| Maintains | Chardan Capital: Buy to Buy | 4/17/2025 |
| Maintains | RBC Capital: Sector Perform to Sector Perform | 4/16/2025 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 4/16/2025 |
Related Tickers
FDMT 4D Molecular Therapeutics, Inc.
3.8300
-1.03%
ACRS Aclaris Therapeutics, Inc.
1.6100
+9.52%
BOLD Boundless Bio, Inc.
1.1800
+5.36%
ENTA Enanta Pharmaceuticals, Inc.
7.11
-1.11%
ANTX AN2 Therapeutics, Inc.
1.0900
-0.91%
ASMB Assembly Biosciences, Inc.
15.99
+2.50%
CRVS Corvus Pharmaceuticals, Inc.
3.7500
-8.98%
VTVT vTv Therapeutics Inc.
16.00
-1.84%
STOK Stoke Therapeutics, Inc.
10.94
+0.37%
RGNX REGENXBIO Inc.
10.08
-0.49%